Geron
Oliver Gessner has a extensive background in business insights, analytics, and market research in the pharmaceutical industry. With experience at companies like Geron Corporation, Genmab, and The Janssen Pharmaceutical Companies of Johnson & Johnson, Oliver has held various leadership roles such as Executive Director, Director, and Associate Director. Oliver holds a Bachelor's degree in Finance and Banking, as well as a Master's degree in Executive Leadership.
This person is not in any offices
Geron
4 followers
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.